Evidence map›Paper›PMID 39231249›Full record

Observational studyThe Journal of clinical endocrinology and metabolism2025

Clinical Features and HLA Genetics Differ in Children at Type 1 Diabetes Onset by Hispanic Ethnicity.

Kagan E Karakus, Theodore Fleury, Erin E Baschal, Kristen A McDaniel, Hyelin Choi, Taylor K Armstrong, Liping Yu, Kimber M Simmons, Aaron W Michels

Abstract readObservational Study
In one paragraph

Observational study in The Journal of clinical endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kagan E KarakusBarbara Davis Center for Diabetes, University of Colorado, Aurora, CO 80045, USA.ORCID 0000-0002-8552-5206
Theodore FleuryBarbara Davis Center for Diabetes, University of Colorado, Aurora, CO 80045, USA.
Erin E BaschalBarbara Davis Center for Diabetes, University of Colorado, Aurora, CO 80045, USA.
Kristen A McDanielBarbara Davis Center for Diabetes, University of Colorado, Aurora, CO 80045, USA.
Hyelin ChoiBarbara Davis Center for Diabetes, University of Colorado, Aurora, CO 80045, USA.
Taylor K ArmstrongBarbara Davis Center for Diabetes, University of Colorado, Aurora, CO 80045, USA.ORCID 0000-0003-4931-2331
Liping YuBarbara Davis Center for Diabetes, University of Colorado, Aurora, CO 80045, USA.ORCID 0000-0003-0664-2154
Kimber M SimmonsBarbara Davis Center for Diabetes, University of Colorado, Aurora, CO 80045, USA.
Aaron W MichelsBarbara Davis Center for Diabetes, University of Colorado, Aurora, CO 80045, USA.ORCID 0000-0003-3766-5244

Funding

University of Colorado Anschutz Medical Campus DRCP30DK116073 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LORI SUSSEL · 2020 to 2026
$10.8M
Multiple Autoantigens/Multiple Epitopes of Type 1DMR01DK032083 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI MICHELS, AARON W · 1986 to 2025
$6.9M
Molecular Dissection of Insulin Targeting in Anti-Islet AutoimmunityR01DK099317 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI AARON W MICHELS, Maki Nakayama · 2013 to 2026
$5.3M
Insulin Specific T Cell Response Shaped by Diabetes Protective MHC Class II MoleculesR01DK108868 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI AARON W MICHELS · 2017 to 2026
$3.6M
Autoantigens targeted by CD8 T cells in type 1 diabetes: from islets to bloodR56DK099317 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI MICHELS, AARON W, NAKAYAMA, MAKI · 2019 to 2019
$194k
MULTIPLE AUTOANTIGENS OF PRETYPE I DMR37DK032083 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI EISENBARTH, GEORGE S · 1992 to 1999
–
NIDDK NIH HHS P30 DK116073NIDDK NIH HHS R01 DK032083NIDDK NIH HHS R01 DK099317NIDDK NIH HHS R01 DK108868NIDDK NIH HHS R37 DK032083NIDDK NIH HHS R56 DK099317NIH HHS DK108868
6 · The paper itself

Abstract

contextType 1 diabetes incidence continues to increase in children, especially among Hispanic White (HW) children.

objectiveWe investigated the clinical, immunologic, and genetic characteristics of HW and non-Hispanic White (NHW) children who presented at type 1 diabetes diagnosis.

methodsIn this single-center, observational study, children who were diagnosed with type 1 diabetes (≤20 years old) and tested for islet autoantibodies within 1 year of diagnosis were included in the study and divided into 2 groups by Hispanic ethnicity.

resultsOf 1297 children, 398 HW children presented with a younger age at diabetes onset (10.2 ± 3.9 vs 11.1 ± 4.1 years, P < .001) and more diabetic ketoacidosis (62.4% vs 51.9%, P < .001) than NHW children (n = 899). There was no difference in sex, A1c levels, or the number and prevalence of islet autoantibodies between the 2 cohorts. A subset of our cohort was human leukocyte antigen (HLA) typed as specific alleles confer strong genetic risk for type 1 diabetes (eg, HLA-DR4 and DQ8). Among 637 HLA-typed children, HW children had a significantly higher prevalence of the DR4-DQ8 haplotype than NHW children (79.1% vs 60.1%, P < .001), and this frequency was much higher than a reference Hispanic population (OR 6.5, 95% CI 4.6-9.3).

conclusionHispanic White children developing type 1 diabetes have a high prevalence of HLA DR4-DQ8, which can be utilized to select individuals for immune monitoring with islet autoantibodies to lessen diabetic ketoacidosis and potentially prevent diabetes onset.

Indexed as

Diabetes Mellitus, Type 1Hispanic or LatinoHLA AntigensAdolescentAge of OnsetAutoantibodiesChildChild, PreschoolDiabetic KetoacidosisFemaleGenetic Predisposition to DiseaseHumansInfantMaleWhiteWhite PeopleAutoantibodiesHLA Antigensdiabetic ketoacidosisethnicityHispanicHLA geneticsislet autoantibodiestype 1 diabetes

Identifiers

PMID39231249
PMCPMC11913109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.